| 000 | 01681 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515170941.0 | ||
| 264 | 0 | _c20090917 | |
| 008 | 200909s 0 0 eng d | ||
| 022 | _a1543-8384 | ||
| 024 | 7 |
_a10.1021/mp800251x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMangipudi, Sriramchandra S | |
| 245 | 0 | 0 |
_aDevelopment of a genetically engineered biomimetic vector for targeted gene transfer to breast cancer cells. _h[electronic resource] |
| 260 |
_bMolecular pharmaceutics _c |
||
| 300 |
_a1100-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
| 650 | 0 | 4 |
_aAdenoviridae _xgenetics |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aBiomimetics |
| 650 | 0 | 4 |
_aBreast Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aCell Nucleus _xmetabolism |
| 650 | 0 | 4 |
_aDNA _xadministration & dosage |
| 650 | 0 | 4 |
_aEndosomes _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aGenetic Engineering |
| 650 | 0 | 4 | _aGenetic Therapy |
| 650 | 0 | 4 |
_aGenetic Vectors _xtherapeutic use |
| 650 | 0 | 4 | _aHemolysis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMicrotubules _xmetabolism |
| 650 | 0 | 4 | _aNanoparticles |
| 650 | 0 | 4 | _aNanotechnology |
| 650 | 0 | 4 |
_aPeptide Fragments _xmetabolism |
| 650 | 0 | 4 | _aSheep |
| 650 | 0 | 4 |
_aTNF-Related Apoptosis-Inducing Ligand _xgenetics |
| 650 | 0 | 4 | _aTransfection |
| 650 | 0 | 4 | _aTumor Cells, Cultured |
| 700 | 1 | _aCanine, Brenda F | |
| 700 | 1 | _aWang, Yuhua | |
| 700 | 1 | _aHatefi, Arash | |
| 773 | 0 |
_tMolecular pharmaceutics _gvol. 6 _gno. 4 _gp. 1100-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1021/mp800251x _zAvailable from publisher's website |
| 999 |
_c18847847 _d18847847 |
||